Literature DB >> 32638568

Omalizumab Treatment in Patients With Cholinergic Urticaria: A Real-World Retrospective Study in Korea.

Ji Hye Kim1, Hae Sim Park2, Young Min Ye2, Yoo Seob Shin2, Hye Ryun Kang3, Soo Jie Chung3, Jeong Hee Choi4,5.   

Abstract

Entities:  

Year:  2020        PMID： 32638568     DOI： 10.4168/aair.2020.12.5.894

Source DB:  PubMed          Journal:  Allergy Asthma Immunol Res        ISSN： 2092-7355            Impact factor:   5.764


× No keyword cloud information.
  2 in total

Review 1.  Cholinergic Urticaria: Subtype Classification and Clinical Approach.

Authors:  Atsushi Fukunaga; Yoshiko Oda; Shinya Imamura; Mayuko Mizuno; Takeshi Fukumoto; Ken Washio
Journal:  Am J Clin Dermatol       Date:  2022-09-15       Impact factor: 6.233

2.  Omalizumab on Chronic Spontaneous Urticaria and Chronic Inducible Urticaria: A Real-World Study of Efficacy and Predictors of Treatment Outcome.

Authors:  Soo Hyun Jeong; Dong Jun Lim; Sung Eun Chang; Kwang Ho Kim; Kwang Joong Kim; Eun Joo Park
Journal:  J Korean Med Sci       Date:  2022-07-11       Impact factor: 5.354
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.